Meridian Co., Ltd. announced that it has reached a major milestone in the execution of its strategic business plan of establishing a significant role in the 9 billion dollar aesthetic market in North America. The company filed a Premarket Notification, or a 510(k) with the
US FDA, to allow it to market the non-invasive Lipo-Laser device for the indication
of body contouring and temporary reduction in the appearance of cellulite. Using
cutting edge laser technology intended specifically for this use, this device
will be the first of its kind that would be cleared by the US FDA.
Market
Wire
Simplifying Global Compliance
Recommended Products
EU MDR Compliance: A Checklist for Meeting Manufacturing, Safety and Performance Requirements
The FDAnews report EU MDR Compliance can help. Our editors have combed through the regulations, picking out the most minute compliance points and building them into a checklist of 200+ requirements you can use to confirm that you are satisfying all the EU mandates for device manufacturing.
Accelerating Generic Drug Development: The FDA’s New Plan for Increasing Generic Competition
Accelerating Generic Drug Development explains the FDA’s new policy and shows how to navigate the new pathway to approval.
Editor's Picks
FDA Issues Warning Over Unapproved Breast Implant Device
The FDA said that the surgeon has been advertising the unapproved device on his web site.
FDA Recognizes Polish, Slovenian Inspections
Regulators on both sides of the Atlantic are optimistic they’ll meet the deadline, which they hope will allow them to direct more inspection resources elsewhere.
FDAnews Device Daily Bulletin
MERIDIAN ANNOUNCES 510K SUBMISSION TO THE FDA FOR THE LIPO-LASER
June 22, 2006
